Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
Nitroheterocyclic and nitroaromatic compounds constitute an enormous range of chemicals whose potent biological activity has significant human health and environmental implications. The biological activity of nitro-substituted compounds is derived from reductive metabolism of the nitro moiety, a process catalyzed by a variety of nitroreductase activities. Resistance of bacteria to nitro-substituted compounds is believed to result primarily from mutations in genes encoding oxygen-insensitive nitroreductases. We have characterized the nfsA and nfsB genes of a large number of nitrofuran-resistant mutants of Escherichia coli and have correlated mutation with cell extract nitroreductase activity. Our studies demonstrate that first-step resistance to furazolidone or nitrofurazone results from an nfsA mutation, while the increased resistance associated with second-step mutants is a consequence of an nfsB mutation. Inferences made from mutation about the structure-function relationships of NfsA and NfsB are discussed, especially with regard to the identification of flavin mononucleotide binding sites. We show that expression of plasmid-carried nfsA and nfsB genes in resistant mutants restores sensitivity to nitrofurans. Among the 20 first-step and 53 second-step mutants isolated in this study, 65 and 49%, respectively, contained insertion sequence elements in nfsA and nfsB. IS1 integrated in both genes, while IS30 and IS186 were found only in nfsA and IS2 and IS5 were observed only in nfsB. Insertion hot spots for IS30 and IS186 are indicated in nfsA, and a hot spot for IS5 insertion is evident in nfsB. We discuss potential regional and sequence-specific determinants for insertion sequence element integration in nfsA and nfsB.
Whiteway
J
J
Biology Department, Carleton University, Ottawa, Ontario, Canada K1S 5B6.
Koziarz
P
P
Veall
J
J
Sandhu
N
N
Kumar
P
P
Hoecher
B
B
Lambert
I B
IB
D000595:Amino Acid Sequence; D001483:Base Sequence; D003001:Cloning, Molecular; D004352:Drug Resistance, Microbial; D019008:Drug Resistance, Neoplasm; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D029968:Escherichia coli Proteins; D008969:Molecular Sequence Data; D009581:Nitrofurans / Q000494:pharmacology*; D009601:Nitroreductases / Q000235:genetics* / Q000378:metabolism; D010100:Oxygen; D017386:Sequence Homology, Amino Acid
D029968:Escherichia coli Proteins; D009581:Nitrofurans; C116053:NfsA protein, E coli; C116054:NfsB protein, E coli; D009601:Nitroreductases; D010100:Oxygen